Oene Mark Van insider trades: Pacific Biosciences of California (PACB) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Oene reports to the SEC
Open-market buys and sales
33 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | PACB | ↓ Sell | 26,911 | $1.13 | $30K | Direct | Aug 18, 2026 (1d) |
| Mar 3, 2026 | PACB | ↓ Sell | 6,504 | $1.51 | $10K | Direct | Mar 4, 2026 (1d) |
| Feb 18, 2026 | PACB | ↓ Sell | 184,897 | $1.59 | $294K | Direct | Feb 19, 2026 (1d) |
| Aug 18, 2025 | PACB | ↓ Sell | 26,836 | $1.31 | $35K | Direct | Aug 20, 2025 (2d) |
| Mar 3, 2025 | PACB | ↓ Sell | 6,486 | $1.41 | $9K | Direct | Mar 5, 2025 (2d) |
| Feb 18, 2025 | PACB | ↓ Sell | 100,773 | $1.88 | $189K | Direct | Feb 19, 2025 (1d) |
| Jan 10, 2025 | PACB | ↓ Sell | 34,405 | $2.03 | $70K | Direct | Jan 10, 2025 (0d) |
| Aug 16, 2024 | PACB | ↓ Sell | 38,011 | $1.66 | $63K | Direct | Aug 20, 2024 (4d) |
| Mar 4, 2024 | PACB | ↓ Sell | 9,186 | $4.87 | $45K | Direct | Mar 6, 2024 (2d) |
| Feb 16, 2024 | PACB | ↓ Sell | 33,560 | $5.96 | $200K | Direct | Feb 21, 2024 (5d) |
| Jan 9, 2024 | PACB | ↓ Sell | 31,012 | $7.77 | $241K | Direct | Jan 10, 2024 (1d) |
| Aug 16, 2023 | PACB | ↓ Sell | 26,102 | $11.00 | $287K | Direct | Aug 18, 2023 (2d) |
| Mar 3, 2023 | PACB | ↓ Sell | 6,268 | $9.49 | $60K | Direct | Mar 6, 2023 (3d) |
| Jan 10, 2023 | PACB | ↓ Sell | 26,722 | $9.53 | $255K | Direct | Jan 11, 2023 (1d) |
| Jan 11, 2022 | PACB | ↓ Sell | 41,480 | $14.23 | $590K | Direct | Jan 13, 2022 (2d) |
| Sep 1, 2020 | ILMN | ↓ Sell10b5-1 | 625 | $355.13 | $222K | Direct | Sep 2, 2020 (1d) |
| Aug 3, 2020 | ILMN | ↓ Sell10b5-1 | 625 | $385.43 | $241K | Direct | Aug 5, 2020 (2d) |
| Jul 1, 2020 | ILMN | ↓ Sell10b5-1 | 625 | $369.40 | $231K | Direct | Jul 6, 2020 (5d) |
| Jun 1, 2020 | ILMN | ↓ Sell10b5-1 | 625 | $361.54 | $226K | Direct | Jun 3, 2020 (2d) |
| May 1, 2020 | ILMN | ↓ Sell10b5-1 | 625 | $316.83 | $198K | Direct | May 5, 2020 (4d) |
| Apr 16, 2020 | ILMN | ↓ Sell10b5-1 | 1,250 | $300.22 | $375K | Direct | Apr 20, 2020 (4d) |
| Feb 5, 2020 | ILMN | ↓ Sell10b5-1 | 625 | $300.24 | $188K | Direct | Feb 6, 2020 (1d) |
| Jan 2, 2020 | ILMN | ↓ Sell10b5-1 | 625 | $330.99 | $207K | Direct | Jan 6, 2020 (4d) |
| Dec 2, 2019 | ILMN | ↓ Sell10b5-1 | 625 | $320.15 | $200K | Direct | Dec 4, 2019 (2d) |
| Nov 1, 2019 | ILMN | ↓ Sell10b5-1 | 625 | $300.10 | $188K | Direct | Nov 5, 2019 (4d) |
| Oct 1, 2019 | ILMN | ↓ Sell10b5-1 | 625 | $304.84 | $191K | Direct | Oct 3, 2019 (2d) |
| Nov 5, 2018 | ILMN | ↓ Sell10b5-1 | 6,835 | $326.11 | $2.2M | Direct | Nov 7, 2018 (2d) |
| Sep 4, 2018 | ILMN | ↓ Sell10b5-1 | 1,091 | $354.18 | $386K | Direct | Sep 6, 2018 (2d) |
| Apr 12, 2018 | ILMN | ↓ Sell10b5-1 | 1,400 | $238.48 | $334K | Direct | Apr 13, 2018 (1d) |
| Feb 16, 2018 | ILMN | ↓ Sell10b5-1 | 1,408 | $228.85 | $322K | Direct | Feb 20, 2018 (4d) |
| Nov 15, 2017 | ILMN | ↓ Sell10b5-1 | 1,250 | $207.76 | $260K | Direct | Nov 15, 2017 (0d) |
| Oct 12, 2017 | ILMN | ↓ Sell10b5-1 | 1,250 | $207.21 | $259K | Direct | Oct 13, 2017 (1d) |
| Sep 12, 2017 | ILMN | ↓ Sell10b5-1 | 9,729 | $211.33 | $2.1M | Direct | Sep 14, 2017 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PACB insiders
Open-market trades in the last 12 months
About Oene Mark Van's insider trades
Oene Mark Van is See Remarks at Pacific Biosciences of California (PACB). Since Sep 12, 2017, Oene has reported no open-market purchases and 33 sales worth $10.7M on SEC Form 4. In the last 12 months: 3 sales ($335K).
18 sales (78% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (14 filings), shares withheld for taxes (8 filings), option exercises (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PACB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.